65 YEARS OF THE DOUBLE HELIX: Classification of endocrine tumors in the age of integrated genomics. Issue 8 (August 2018)

• Record Type: Journal Article
• Authors: Giordano, Thomas J
• Is Part Of: Endocrine-related cancer. Volume 25:Issue 8(2018)
• Page Start: T171
• Page End: T187
• Publication Date: 2018-08
• Subjects: neoplasia -- neuroendocrine tumors -- molecular genetics -- thyroid -- adrenal cortex; Endocrine glands -- Cancer -- Periodicals; Endocrinology -- Periodicals; Cancer -- Endocrine aspects -- Periodicals; 616.9944005
• DOI: 10.1530/ERC-18-0116
• Languages: English
• ISSNs: 1351-0088

Abstract

Abstract : The classification of human cancers represents one of the cornerstones of modern pathology. Over the last century, surgical pathologists established the current taxonomy of neoplasia using traditional histopathological parameters, which include tumor architecture, cytological features and cellular proliferation. This morphological classification is efficient and robust with high reproducibility and has served patients and health care providers well. The most recent decade has witnessed an explosion of genome-wide molecular genetic and epigenetic data for most cancers, including tumors of endocrine organs. The availability of this expansive multi-dimensional genomic data, collectively termed the cancer genome, has catalyzed a re-examination of the classification of endocrine tumors. Here, recent cancer genome studies of various endocrine tumors, including those of the thyroid, pituitary and adrenal glands, pancreas, small bowel, lung and skin, are presented with special emphasis on how genomic insights are impacting endocrine tumor classification.